Founded and managed by the Lacorte brothers, PharmaNutra S.p.A. was born in 2003 with the aim of developing nutritional supplements and innovative medical devices, overseeing the whole production process, from the development of proprietary raw materials to the distribution of the finished product. With its products distributed worldwide, in less than 20 years the company has succeeded in making its mark as a leading player in the iron-based oral nutritional supplements market, where it boasts major patents linked to Sucrosomial® Technology, and it is also considered to be one of the emerging top players in the sector of medical devices for the recovery of joint capacity.
In 2010, PharmaNutra invested in the creation of a new company, aiming to respond to the increasing health needs of children as a starting point for a healthier society. This led to the establishment of Junia Pharma S.r.l., the company specialised in the development and distribution of paediatric medicines, medical devices, OTC products and nutritional supplements. With its constant attention to the needs of the paediatric world and the quality and safety of its products, today Junia Pharma is present in Italy and in many foreign countries, acting as a point of reference for general practitioners and families.
Alesco S.r.l. was established in 2000 to stand out on the nutraceutical market for the high scientific value of the raw materials distributed. Thanks to its ongoing R&D investments, company activities focussed on studying iron and minerals and implemented the Sucrosomial® Technology in 2010. In under ten years, that unique, innovative delivery system has revolutionised the martial therapies and mineral-based supplements sector. Alesco active principles are considered the most effective on the market and are used in the pharmaceutical, food and cosmetic sectors.
Akern S.r.l. was founded in 1980, dedicated to the research, development and production of medical instruments and software for monitoring body composition using bioimpedance techniques. The company mission is to support doctors and researchers in their challenge to fight chronic degenerative diseases, guaranteeing clinically significant results to support diagnosis and the choice of treatment. Over the years, Akern has developed technologies that have allowed the company to be recognised in Europe as a benchmark for body composition science. Akern joined the PharmaNutra Group in 2022.